Eugene Schuster

Institute of Cancer Research

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Cancer Biology Cancer Biology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (12)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (5)

Nazif Alic

University College London

UNITED KINGDOM

View details

Richard Buus

Institute of Cancer Research

UNITED KINGDOM

View details

Andrew Jenks

Institute of Cancer Research

UNITED KINGDOM

View details

Robin Jones

Consultant Medical Oncology, Head of Sarcoma Unit,

Royal Marsden NHS Foundation Trust

UNITED KINGDOM

View details

Ivana Sestak

Associated Professor in Medical Statistics

Queen Mary University of London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Eugene Schuster

Research Interests

Explore related searches

Contact this professor

Articles (12)

Clinical and molecular predictors of very late recurrence in oestrogen receptor-positive breast cancer patients.

Molecular profiling of aromatase inhibitor sensitive and resistant ER+HER2- postmenopausal breast cancers

The proteomic landscape of soft tissue sarcomas

Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor-Positive Breast Cancer.

Elacestrant demonstrates strong anti-estrogenic activity in PDX models of estrogen-receptor positive endocrine-resistant and fulvestrant-resistant breast cancer.

Relationship between ER expression by IHC or mRNA with Ki67 response to aromatase inhibition: a POETIC study.

HER2-enriched subtype and novel molecular subgroups drive aromatase inhibitor resistance and an increased risk of relapse in early ER+/HER2+ breast cancer

Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor-positive Breast Cancers.

Development and validation for research assessment of Oncotype DX® Breast Recurrence Score, EndoPredict® and Prosigna®

Impact of the menstrual cycle on commercial prognostic gene signatures in oestrogen receptor-positive primary breast cancer.

Increased mitochondrial and lipid metabolism is a conserved effect of Insulin/PI3K pathway downregulation in adipose tissue

Tumour kinome re-wiring governs resistance to palbociclib in oestrogen receptor positive breast cancers, highlighting new therapeutic modalities.

Collaborators (5)

Nazif Alic

Richard Buus

Andrew Jenks

Robin Jones

Ivana Sestak

Make your next move.